Safe and efficient drugs to combat the current COVID-19 pandemic are urgently needed. In
this context, we have analyzed the anti-coronavirus potential of the natural product …

Since its appearance, the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2),
the causal agent of Coronavirus Disease 2019 (COVID-19), represents a global problem for …

Abstract The coronavirus disease 2019 (COVID-19) can result in a hyperinflammatory state,
leading to acute respiratory distress syndrome (ARDS), myocardial injury, and thrombotic …

Current data suggest that infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) causing corona virus disease-19 (COVID-19) seems to follow a more severe …

Background: Viral infectivity depends on interactions between components of the host cell
plasma membrane and the virus envelope. Here we review strategies that could help stem …

Abstract Coronavirus disease 2019 (COVID19) is a respiratory infection caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China in …

Cyclodextrins, since their discovery in the late 19th century, were mainly regarded as
excipients. Nevertheless, developments in cyclodextrin research have shown that some of …

Membrane rafts are dynamic, small (10–200 nm) domains enriched with cholesterol and
sphingolipids that compartmentalize cellular processes. Rafts participate in roles essential to …

The recently emerged SARS-CoV-2 is the cause of the global health crisis of the coronavirus
disease 2019 (COVID-19) pandemic. No evidence is yet available for CoV infection into …

Host cholesterol metabolism remodeling is significantly associated with the spread of human
pathogenic coronaviruses, suggesting virus-host relationships could be affected by …